Evolution and Clinical Advances of Platelet-Rich Fibrin in Musculoskeletal Regeneration
Bioengineering · 03.01.2023 · 10 (1) · 58
DOI: 10.3390/bioengineering10010058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 03.01.2023. Verfasst von Ragunanthan Narayanaswamy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Rathimed Speciality Hospital, Chennai 600040, India. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Over the past few decades, various forms of platelet concentrates have evolved with significant clinical utility. The newer generation products, including leukocyte-platelet-rich fibrin (L-PRF) and advanced platelet-rich fibrin (A-PRF), have shown superior biological properties in musculoskeletal regeneration than the first-generation concentrates, such as platelet-rich plasma (PRP) and plasma rich in growth factors. These newer platelet concentrates have a complete matrix of physiological fibrin that acts as a scaffold with a three-dimensional (3D) architecture. Further, it facilitates intercellular signaling and migration, thereby promoting angiogenic, chondrogenic, and osteogenic activities. A-PRF with higher leukocyte inclusion possesses antimicrobial activity than the first generations. Due to the presence of enormous amounts of growth factors and anti-inflammatory cytokines that are released, A-PRF has the potential to replicate the various physiological and immunological factors of wound healing. In addition, there are more neutrophils, monocytes, and macrophages, all of which secrete essential chemotactic molecules. As a result, both L-PRF and A-PRF are used in the management of musculoskeletal conditions, such as chondral injuries, tendinopathies, tissue regeneration, and other sports-related injuries. In addition to this, its applications have been expanded to include the fields of reconstructive cosmetic surgery, wound healing in diabetic patients, and maxillofacial surgeries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, Rathimed Speciality Hospital, Chennai 600040, India.
- Department of Orthopaedics, All India Institute of Medical Sciences, Bhubaneswar 751019, India.
- Indian Stem Cell Study Group (ISCSG) Association, Lucknow 226010, India.
- Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
- BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
- Department of Orthopaedics, ACS Medical College and Hospital, Dr. MGR Educational and Research Institute, Chennai 600056, India.
ORCID-Profile: Bishnu Prasad Patro, Naveen Jeyaraman, Prakash Gangadaran, Ramya Lakshmi Rajendran, Arulkumar Nallakumarasamy, Madhan Jeyaraman, Prasanna Ramani, Byeong-Cheol Ahn
Förderung
- National Research Foundation of Korea
Zitieren
APA
Narayanaswamy, R., Patro, B. P., Jeyaraman, N., Gangadaran, P., Rajendran, R. L., Nallakumarasamy, A., Jeyaraman, M., Ramani, P., & Ahn, B. C. (2023). Evolution and Clinical Advances of Platelet-Rich Fibrin in Musculoskeletal Regeneration. Bioengineering, 10(1), 58. https://doi.org/10.3390/bioengineering10010058
Vancouver
Narayanaswamy R, Patro BP, Jeyaraman N, Gangadaran P, Rajendran RL, Nallakumarasamy A, et al. Evolution and Clinical Advances of Platelet-Rich Fibrin in Musculoskeletal Regeneration. Bioengineering. 2023;10(1):58. doi:10.3390/bioengineering10010058
BibTeX
@article{Narayanaswamy2023,
author = {Narayanaswamy, Ragunanthan and Patro, Bishnu Prasad and Jeyaraman, Naveen and Gangadaran, Prakash and Rajendran, Ramya Lakshmi and Nallakumarasamy, Arulkumar and Jeyaraman, Madhan and Ramani, Prasanna and Ahn, Byeong-Cheol},
title = {Evolution and Clinical Advances of Platelet-Rich Fibrin in Musculoskeletal Regeneration},
journal = {Bioengineering},
year = {2023},
volume = {10},
number = {1},
pages = {58},
doi = {10.3390/bioengineering10010058}
}
EUVIMED